Erythropoiesis, the production of red blood cells, occurs primarily in the bone marrow of adults. Specifically, the pelvis, spine, ribs, sternum, and skull are the major production sites, with the pelvis contributing the most due to its large size and rich marrow content. But this wasn’t always the case in your body. Before birth, red blood cell production migrates through several organs in a carefully timed sequence.
Primary Sites in Adults
In adults, red blood cell production is concentrated in bones that retain red marrow. The pelvis is the single largest contributor, housing a substantial volume of active marrow. The vertebrae of the spine collectively offer a large surface area for production, while the ribs and sternum also play significant roles. The skull contributes as well, though to a lesser degree than the other sites.
These locations matter because not all bone marrow is actively producing blood cells. At birth, nearly every bone contains red marrow (the active, blood-producing type). Over the first two decades of life, much of that red marrow converts to yellow marrow, which is mostly fat and largely inactive. This conversion follows a predictable pattern: in the long bones of the legs, for example, the shaft converts first (between ages 1 and 10), followed by the ends of the bone (ages 10 to 20), with the adult pattern fully established by around age 24. By adulthood, the flat bones of the pelvis, spine, ribs, sternum, and skull are the main reservoirs of red marrow that remain.
How the Location Shifts Before Birth
During fetal development, red blood cell production moves through three distinct organs before settling in the bone marrow. The sequence is tightly programmed and follows a specific timeline.
The process begins in the yolk sac during the first two weeks after conception. This earliest wave of red blood cell production is brief, occurring only while the yolk sac is developing its blood vessel network. The cells produced here are “primitive” red blood cells, structurally different from the mature ones your body makes later in life.
By the 7th week of gestation, blood-forming stem cells migrate to the fetal liver, which then becomes the dominant production site. The liver remains the primary source of red blood cells for much of pregnancy. Around the 20th week, the spleen briefly joins in, contributing to red blood cell production for a short window. At the same time, stem cells begin seeding the bone marrow, setting the stage for the permanent transition. As the bone marrow ramps up, the liver and spleen gradually wind down, and by the time of birth, the marrow has taken over almost entirely.
The Hormone That Controls It All
Where red blood cells are made is one question. What tells the body to make them is another. The answer is erythropoietin, a hormone that signals the bone marrow to ramp up production when oxygen levels drop.
In adults, the kidneys produce the vast majority of erythropoietin. This represents a switch from fetal life, when the liver was the major source. Research in animal models shows this liver-to-kidney transition begins during the final third of pregnancy but isn’t fully complete until several weeks after birth. Thyroid hormone levels and oxygen supply influence the timing of this switch. Once complete, the kidneys become so dominant that severe kidney disease can cause significant anemia simply because erythropoietin production drops.
Inside the Bone Marrow: How Red Blood Cells Form
Red blood cells don’t just appear in the marrow randomly. They develop within specialized clusters called erythroblastic islands. Each island consists of a central “nurse” macrophage (a type of immune cell) surrounded by a ring of developing red blood cells at various stages of maturation.
The central macrophage plays several roles. Early in the process, it provides nutrients and survival signals to the immature red blood cells clustered around it. It also helps regulate which cells live and which undergo programmed cell death, keeping production in balance. At the end of the maturation process, when a developing red blood cell ejects its nucleus to become the flexible, biconcave disc you’d recognize under a microscope, the macrophage engulfs and disposes of that discarded nucleus. There’s also evidence that the macrophage actively promotes the ejection process itself. These nurse cells are uniquely suited to the job: they’re highly adhesive, efficient at engulfing cellular debris, and unlike other immune cells, they don’t release toxic compounds that would damage the fragile developing cells around them.
How Long the Process Takes
From the earliest committed precursor cell to a functional red blood cell, the process takes roughly three weeks in the bone marrow. The final stage produces a reticulocyte, a nearly mature red blood cell that still contains some residual cellular machinery for making hemoglobin. Reticulocytes spend one to two days in the marrow before entering the bloodstream, where they lose that remaining machinery within another one to two days and become fully mature red blood cells.
In healthy adults, reticulocytes make up 0.5% to 2.5% of circulating red blood cells (2% to 6% in infants). This low percentage reflects the steady-state balance between old red blood cells being removed and new ones entering circulation. A reticulocyte count above or below this range is one of the simplest clues to whether the bone marrow is producing red blood cells at an appropriate rate.
Nutrients the Bone Marrow Needs
Producing red blood cells at the rate of roughly 2 million per second requires a steady supply of raw materials. Iron is the most critical, forming the core of hemoglobin, the protein that carries oxygen. Without enough iron, the marrow produces smaller, paler red blood cells that carry less oxygen.
Folate and vitamin B12 are also essential. Both are needed for DNA synthesis during the rapid cell divisions that occur as red blood cells mature. When either is deficient, the marrow produces abnormally large, immature-looking cells, a condition called megaloblastic anemia. Folate deficiency in particular is common in populations with low fruit and vegetable intake, and can affect up to 40% of pregnant women in some regions.
When Production Moves Outside the Marrow
In certain diseases, red blood cell production reactivates in organs that handled the job during fetal life, primarily the spleen and liver. This is called extramedullary hematopoiesis, and it’s essentially the body’s backup plan when the bone marrow can’t keep up.
The most common triggers are conditions that damage or crowd out normal marrow function. Myelofibrosis, a disease where scar tissue replaces healthy marrow, is the classic example, with the spleen and liver resuming production. Other causes include leukemias, lymphomas, thalassemia, hemolytic anemia, and even severe infections or chronic inflammation. In rare cases, blood cell production has been documented in unusual locations like the lungs, skin, central nervous system, and stomach.
This backup production is a compensatory mechanism, not a cure. The organs recruited for extramedullary production are less efficient at it than bone marrow, and the process often causes the spleen or liver to enlarge significantly. It signals that something has gone seriously wrong with normal marrow function.